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H I G H L I G H T S
• Resources targeted to Indigenous smoking cessation in pregnancy were well-received.• Health staff were motivated by engagement with Indigenous pregnant women.• Many Indigenous women made quit attempts, and 13.8% quit smoking.• ICAN QUIT in Pregnancy was feasible and acceptable to Aboriginal Medical Services.• Modifications were recommended by health staff to trial design and survey length.










A B S T R A C T
Background: Many health providers (HPs) lack knowledge, confidence, optimism and skills in addressing
smoking with pregnant women. This study aimed to explore the feasibility and acceptability of a) a co-designed
multi-component intervention for HPs at Aboriginal Medical Services (AMSs) in culturally-targeted pregnancy-
specific smoking cessation care and b) the study design.
Methods: Using a randomised step-wedge cluster design, the Indigenous Counselling And Nicotine (ICAN) QUIT
in Pregnancy Trial was evaluated across six AMSs in three Australian states. HPs were provided educational
resource packages including live interactive webinars, treatment manuals, patient resources, carbon monoxide
(CO) meters, and oral Nicotine Replacement Therapy (NRT). Feasibility was assessed through recruitment and
retention rates of both pregnant women (12-weeks) and HPs (end of study) as well as the potential to improve
women's quit rates. Qualitative interviews with staff post-trial explored acceptability of the intervention and
study, based on capability, opportunity and motivation from the Behaviour Change Wheel.
Results: Pregnant women (n= 22; 47% (95% CI: 32%, 63%) eligible) and HPs (n=50; 54% (95% CI: 44%,
64%) eligible) were recruited over 6months with retention rates of 77% (95% CI: 57%, 90%) and 40% (95% CI:
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28%, 54%) respectively. Self-reported 12-week 7-day point-prevalence abstinence was 13.6% (n=3) and va-
lidated abstinent with CO readings ≤6 ppm. Staff interviewed regarding intervention implementation high-
lighted the importance of provision and use of resources, including training materials, patient resources, CO
meters and oral NRT. Resources helped increase capability and opportunity, restructure the environment, and
provided social comparison and modelling. Staff were motivated by greater engagement with pregnant women
and seeing the women's reductions in CO readings. Having the intervention at the AMSs improved organisational
capacity to engage with pregnant women. Staff reported changes to their routine practice that were potentially
sustainable. Recommendations for improvement to the implementation of the intervention and research in-
cluded reducing training length and the tasks related to conducting the study.
Conclusion: ICAN QUIT in Pregnancy was a pilot study with the ability to enrol Indigenous women. It was
feasible to implement and acceptable to most staff of the AMSs in three states, with modifications recommended.
Smoking in pregnancy is a key challenge for Indigenous health. The intervention needs to be evaluated through a
methodologically rigorous fully-powered study to determine the efficacy of outcomes for women.
Trial registration: Australian and New Zealand Clinical Trials Registry, ACTRN12616001603404. Registered 21
November 2016 - retrospectively registered, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?
id=371778
1. Background
Tobacco smoking is diminishing among pregnant women globally,
(Murthy, 2017; Reitan & Callinan, 2017) but smoking rates among
Australian Indigenous pregnant women remain higher than their gen-
eral population counterparts (age-standardised percentages of 44%
compared to 12% respectively in the first 20 weeks of pregnancy).
(Australian Institute of Health and Welfare, 2016) In some states, such
as New South Wales, the gap is widening (a three-fold to six-fold in-
crease over a decade), (Health, 2015) and smoking rates were reported
as increasing among pregnant Aboriginal women in the Northern Ter-
ritory (from 42% in 1997–1999 to 52% in 2009–2011). (Department of
Health, 2014; Li & O'Neil, 2018) Smoking is a major reversible risk
factor for obstetric complications. (Hofhuis, de Jongste, & Merkus,
2003) Maternal smoking in pregnancy is associated with multiple ad-
verse health effects for the unborn baby and affects the early lives of the
offspring. (Hofhuis et al., 2003) Many non-communicable diseases are
associated with in utero exposure to chemicals from tobacco, such as
chronic heart and lung diseases, cancer, obesity and diabetes. (Hofhuis
et al., 2003) Tobacco smoking has also been identified as a major
preventable cause of health inequities suffered by women experiencing
psychosocial disadvantage. (Chamberlain et al., 2017)
Pregnancy has a unique set of circumstances that can make stopping
smoking more difficult for women. Women from the general pregnant
population report many barriers to quitting, including: lack of knowl-
edge, stigma, partner smoking, fears that quitting risks disruption of
social networks, boredom and isolation, need to balance own needs and
that of the unborn baby, rebellion, belief that risks of smoking in
pregnancy are exaggerated, psychosocial stress, financial stress, in-
timate partner violence, depression, half-hearted support from HPs, and
negative attitudes towards pharmacotherapy. (Bottorf et al., 2014;
Crane, Hawes, & Weinberger, 2013; Flemming, Graham, McCaughan,
Angus, & Bauld, 2015; Flemming, Heirs, Fox, & Sowden, 2013;
Flemming, Md, & Graham, 2014; Ingall, 2010; Rhodes-Keefe, 2015; S
Schneider & Schuetz, 2010) Within the Indigenous context during
pregnancy these barriers are compounded by additional factors, (Bovill
et al., n.d.; Gould et al., 2013; Gould et al., 2017; Gould, Lim, & Mattes,
2017; Gould, Munn, Watters, McEwen, & Clough, 2013; Gould, Patten,
Glover, Kira, & Jayasinghe, 2017) including social-cultural norms,
smoking as a stress reduction and coping mechanism due to higher rate
of multiple life stressors compared to the non-Indigenous population,
lack of culturally-tailored content triggering fear control responses and
avoidance or refutation of messages and inconsistent advice from HPs
to quit versus cut down subsequently resulting in inconsistent appli-
cation of evidence-based approaches such as nicotine replacement
therapy (NRT). (Bar-Zeev et al., 2017; Bar-Zeev, Lim, Bonevski,
Gruppetta, & Gould, 2018)
Systematic reviews on psychosocial interventions for smoking
cessation in pregnancy have shown that interventions such as coun-
selling (RR 1.44, 95% CI 1.19 to 1.73) (Chamberlain et al., 2017) and
NRT (RR 1.41, 95 CI 1.03 to 1.93) (Coleman, Chamberlain, Davey,
Cooper, & Leonardi-Bee, 2015) can be effective to aid quit attempts
compared to usual care. However, a Cochrane review pooled results
from four interventions (three were tailored counselling, and one used
incentives) conducted with Indigenous pregnant women, and did not
show a significant effect. (Chamberlain et al., 2017) Even though these
four relatively small studies have been conducted world-wide among
Indigenous pregnant women, this is considered a very limited amount
of research compared to> 100 trials with over 28,000 women in the
broader pregnant population. The Cochrane review highlights the im-
portance of considering context in program design, as the very high
baseline prevalence of smoking among Indigenous people, may over-
whelm the capacity of individuals to quit smoking. Suggested are
comprehensive approaches and concurrent environmental interven-
tions, such as supporting smoke-free homes, and culturally-targeted
support. Despite interventions being reported as feasible and acceptable
to Indigenous communities, there have been challenges with im-
plementation in the studies conducted to date.
Conversely, a Cochrane review of smoking cessation interventions
culturally-tailored for smoking cessation among the general population
of Indigenous adults demonstrated a positive effect on cessation (RR
1.43, 95% CI 1.03 to 1.98; p=0.032). (Carson et al., 2012)
Unique barriers pregnant Indigenous women face for smoking ces-
sation require unique interventions that consider these compounding
factors. Cochrane and other authoritative reviews highlight the need for
further research into targeted approaches for women in high priority
groups, including women experiencing psychosocial disadvantage, and
Indigenous pregnant women. (Chamberlain et al., 2017) Recommended
approaches for further research stress the importance of considering
cultural and other contexts to enable specific needs of subpopulations to
be addressed and ensure intervention appropriateness for respective
settings. Trials during pregnancy can also be challenging to implement
as research needs to be conducted in a small window of time with other
confounding factors such as women delivering early, or moving, or
becoming unwell.
Pilot studies that describe intervention development are required to
assess intervention feasibility, acceptability and potential for uptake
prior to large investment into fully-powered studies. To date, few fea-
sibility studies of smoking cessation for Indigenous women have been
conducted. Of the available evidence from four feasibility studies
among pregnant Indigenous women, recruitment rates range between
12%–58%, and retention rates from 37% to 86% and outcomes mea-
sures reported for feasibility and acceptability vary. (Glover, Kira,
Walker, & Bauld, 2015; Passey & Stirling, 2018; Patten et al., 2010)
Only one study, Passey et al., reported process measures in detail.
(Passey & Stirling, 2018) A full randomised controlled trial (RCT) of
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smoking cessation intervention in Australian Indigenous pregnant
women had a high recruitment rate of 69% (n=263/379 women) over
a period of two years, and a 67% retention rate, yet a non-significant
increase in quit rates. (Eades et al., 2012) Although this trial was fea-
sible in relation to recruitment, the paper reported implementation
problems, which may have impacted trial outcomes. These im-
plementation issues for an intervention, and the research design may be
picked up in a pilot study. This highlights the importance of under-
standing implementation and context of both an intervention and the
research to maximise conditions for success, as both aspects may op-
erate independently.
In the context of so few trials being conducted in an Indigenous
setting for pregnant women who smoke, the seriousness of the effects of
smoking across the lifespan for Indigenous Australians, and the need to
develop more robust evidence about the implementation of smoking
cessation during pregnancy for Indigenous women, we aimed to ex-
amine the feasibility and acceptability of a) a multi-component cultu-
rally-tailored smoking cessation intervention for Indigenous pregnant
women called Indigenous Counselling and Nicotine (ICAN) QUIT in
Pregnancy, and b) the step-wedge trial design. A multi-component in-
tervention was developed to simultaneously target services, HPs and
end-users (pregnant women using the services), as multiple factors have
been identified that are critical to address for a targeted approach to
smoking cessation in this population. (Gould, 2014; Passey, Bryant,
Hall, & Sanson-Fisher, 2013) This paper reports on the feasibility and
acceptability of this intervention, the implementation issues en-
countered, and participant recommendations for a larger trial. (Gould,
2017)
2. Methods
2.1. Study design, setting and participants
This pilot study used a randomised step-wedge design in six
Aboriginal Medical Services (AMSs) in Australia: four services in New
South Wales, one in Queensland, and one in South Australia from
November 2016 to September 2017. The published a priori protocol is
described in brief. (Bar-Zeev et al., 2017) The AMSs were all primary
health services that are controlled by an Aboriginal community board.
An Aboriginal community-controlled health service aims to deliver
holistic, comprehensive, culturally appropriate health care to the
community that controls it.
A step-wedge design is an alternative to a parallel cluster trial de-
sign, which is commonly used for the evaluation of service delivery at
the level of the cluster. (Hemming, Haines, Chilton, Girling, & Lilford,
2015) In a step-wedge design, each cluster provides before and after
observations and switches from control to becoming exposed to the
intervention, but the start times for the clusters are staggered (see
schema in Fig. 1). (Hemming et al., 2015)This design was chosen as
having potential for a full trial as an alternative to a standard rando-
mised controlled trial (RCT). The advantage would be that all sites
receive the intervention in a timelier fashion for example compared to a
standard cluster RCT or wait-list intervention. If the pilot phase was
feasible, the trial could continue to recruit more services under the
same design. The services were randomised in pairs, to when they
would receive treatment cross-over (see Fig. 1) using simple randomi-
sation by a senior statistician (CO). The intervention was delivered for a
period of 2-months, with delivery of the intervention staggered by one
month between each step (see Fig. 1). Inclusion criteria for services
were AMSs who consulted Indigenous pregnant women, employed at
least one general practitioner (GP), had contact with 20 pregnant
women who smoke per annum, and were able to recruit and follow-up
patients for the study. There were no specific exclusion criteria for
services. Each pair of services had a two-month pre-training period in
which to recruit women and perform usual care, followed by a month
designated for the training, and then a post-training period when they
continued recruiting and following up pregnant women (see Fig. 1). All
HPs at a service, and their managers or other staff were welcome to
participate in the webinar training. Pregnant women were eligible
provided they were current smokers, were up to 28-weeks' gestation,
aged 16 years or over, and expecting an Indigenous baby. An exclusion
criterion was if a woman was unable to give informed consent.
Expected sample size for HP was 30–60, with ~80% expected to
complete the training. Expected sample for women was 60 (estimate of
10 women per service, range 50–80) with recruitment rate expected to
be ~50%. (Bar-Zeev, Bonevski, Bovill, et al., 2017). There is limited
data available to guide the estimation of a sample size for this study.
Therefore, samples sizes were pragmatically estimated based on in-
formation obtained from colleagues who work within AMSs.
2.2. Intervention
The ICAN QUIT in Pregnancy study was collaboratively designed
(Bar-Zeev, Bonevski, Bovill, et al., 2017; Gould et al., 2017) following
in-depth community consultation. (Bovill et al., 2017) This occurred
under the guidance of a Stakeholder and Consumer Aboriginal Advisory
Panel to produce a suite of training and educational resources for HPs
and the pregnant Indigenous women they consult, (Bar-Zeev et al.,
2017) based on the Behaviour Change Wheel (BCW) and Theoretical
Domains Framework (TDF). (Gould, Bar-Zeev, et al., 2017) The
Fig. 1. Schema of Step-Wedge Cluster Randomised Design for ICAN QUIT in Pregnancy (reproduced with permissions from authors) (Bar-Zeev, Bonevski, Bovill,
et al., 2017).
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behaviour change targeted was HP provision of smoking cessation care
for pregnant women. This was to be achieved through the intervention
components at the HP level of: education, training and enablement,
social modelling, environmental restructuring, incentivising (non-fi-
nancial incentives) and persuasion. (Bar-Zeev, Bonevski, Bovill, et al.,
2017; Gould, Bar-Zeev, et al., 2017)
Planned intervention components included:
1. An education resource package to support interactive webinar
training delivered in real time by Tobacco Treatment Specialists via
Zoom software (Zoom Video Communications, San Jose, California,
U.S.A). Three one-hour sessions were delivered in a single 3-h
period. Recorded sessions were available for HPs who missed live
sessions. Supportive materials included a treatment manual, a
desktop guide (as a mouse pad), a Flipchart to guide the HP-patient
consultation, several educational posters, and a patient booklet.
Development and pre-testing of these resources have been detailed
elsewhere. (Bar-Zeev et al., 2017; Bovill et al., 2017; Gould, Bar-
Zeev, et al., 2017)
2. Oral forms of NRT. As oral forms of NRT are recommended as a first
option before NRT patches are prescribed, and not subsidised in
Australia at the time of the study, AMS were provided with sample
packs, and supplies to dispense on site, via a voucher system.
3. A carbon monoxide (CO) breath meter specifically designed for use
with pregnant smokers (Bedfont Scientific piCOBaby™
Smokerlyzer®) to measure exhaled CO, as a biological indicator of
tobacco smoking, and a computer tablet were supplied.
4. Audit and feedback to report to AMS their performance as a whole
service on prescribing rates of NRT to pregnant patients who smoke
during the study period
2.3. Recruitment and intervention delivery
A Research Facilitator (RF) was engaged at each service (selected by
individual AMSs) to recruit women to the trial, collect data and follow
up participants. Women were recruited to the trial by posters displayed
in waiting room or clinic areas, a pamphlet on the trial given to in-
terested women, and other local means, such as informing women
about the trial through community events or newsletters, and word of
mouth. Women were followed up by the RF by planned appointments,
at routine clinic visits, or by contacting women via their preferred
channels.
Shopping vouchers of Australian Dollar (AUD) $20 value each were
given to women at each evaluation point of baseline, 4-weeks and 12-
weeks (not able to be used to purchase tobacco or alcohol). Services
were reimburse AUD $6000 in three installments of AUD $2000 to
recompense the RFs time. The RFs were trained by YBZ face to face
during site visits, and a study briefing via Zoom, and supported by a
research assistant (LP) by weekly telephone calls and emails.
2.4. Outcome measures and data collection
The primary outcome measure was feasibility determined through
recruitment rate (number of participants recruited divided by number
deemed as eligible and therefore invited to the trial by the RF) and
retention rates for pregnant women (completion of 12-weeks follow-up
survey) and HPs (completion of one follow-up survey). We did not pre-
determine a recruitment threshold below which we considered the
study not to be feasible but would use the information gained to make
improvements to conduct a larger trial.
Secondary outcomes included:
a) Survey completion rates for pregnant women and HP participants;
b) Rate of agreement to audio-recording of consultations for women
and health providers;
c) Acceptance and adherence of NRT among pregnant women;
d) Efficacy of ICAN QUIT in Pregnancy program measured by various
indicators: self-reported; biochemically validated by CO readings
≤6 ppm indicating smoking abstinence; 7-day point prevalence;
continuous abstinence using the Russell Standard Clinical – assessed
as abstinent if ‘not a puff’ since quit date, or allowing slippage of 1–5
cigarettes, (West, 2005) at each time point, and number of women
making a quit attempt;
e) Intervention adherence to training for the ICAN QUIT in Pregnancy
program for both eligible HPs and consenting HPs and provision of
NRT;
f) Use of research study forms;
g) Feasibility of obtaining monthly data on NRT prescriptions and
smoking characteristics of pregnant women attending the service;
h) Fidelity of training timing (proportion of services trained as sched-
uled);
i) Views of pregnant women participants about critical factors for
success (survey);
j) Views of staff from interviews post-study.
Data collection sources included study research logs and surveys
collected by Qualtrics software (Provo, Utah, USA).
2.4.1. Surveys
The surveys included a ‘smoking characteristics survey’ (a 56-item
survey collecting data on attitudes to smoking, intentions to quit
smoking and smoking behaviours – with additional demographic
questions at baseline), and a previously validated Growth and
Empowerment Measure (GEM): these were completed at four and
12weeks, as well as the ‘women’s checklist’ (a 10-item survey asking
about the smoking cessation care the woman had received that day)
completed, after each consultation at the service and after study visits.
The GEM is an instrument to measure dimensions of empowerment as
defined and described by Aboriginal people, developed in collaboration
with Aboriginal Australians and psychometrically validated in
Aboriginal populations. (Haswell et al., 2010) The smoking character-
istics survey was validated in an Aboriginal community-based study,
(Gould, Watt, Cadet-James, & Clough, 2015; Gould, Watt, McEwen,
Cadet-James, & Clough, 2014) and previously used with pregnant
Aboriginal women. (Bovill et al., 2018; Gould, Bovill, et al., 2017) The
women's checklist was used for the first time in this study. A ‘health
provider survey’ (102-items completed pre-training included baseline
demographic characteristics, and knowledge, attitudes and practices,
and also at one-month post-training, and at the end of the study). The
health provider survey was previously validated in a national study of
Australian general practitioners and obstetricians. (Bar-Zeev et al.,
2018; Bar-Zeev, Bonevski, Twyman, et al., 2017)
2.4.2. Critical factors survey
This was used to assess study acceptability from the women parti-
cipants' viewpoint. The critical success survey was previously devel-
oped through an analysis of Indigenous youth social and emotional
well-being programs. (Haswell, Blignault, Fitzpatrick, & Jackson-
Pulver, 2013) Pregnant participants were presented with nine critical
factors that are theorised to be important to a successful program, at the
end of the study. This survey measures nine factors relevant to an
empowerment-based program, including adopting a commitment to
working from strengths; being patient to develop the relationship bond;
modelling reliability and being consistent; facilitating connection to
culture; adopting a non-judgemental approach; setting rules and
boundaries; modelling openness, honesty, hope and trust; maximising
opportunity for choice making, self-motivation, feeling safe to try new
things; and celebrating small achievements and positive changes. For
example, the first critical success factor was “Adopting full commitment
to working from strengths, not seeking to correct deficits”. For each
critical factor participants were asked to indicate, using a five-point
Likert scale: (Reitan & Callinan, 2017) how important they believed the
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factor was in order for the program to work well, with response options
including “not at all”, “a little”, “moderate”, “very” and “absolutely
essential”; and (Murthy, 2017) how well they thought the program
achieved that factor, with response options including: “poorly,”
“slightly,” “moderately,” “very” and “extremely.” For both questions,
responses were dichotomised as “not at all/a little/moderate” vs. “very/
absolutely essential”, and “poorly/slightly/moderately” vs. “very/ex-
tremely”, respectively.
2.4.3. Interviews
Study and intervention acceptability was assessed qualitatively
using semi-structured moderator guides tailored for the manager of the
AMSs, the RF or the HPs. The intention was to interview one of each HP
type (GP, Aboriginal Health Worker, midwife or nurse) from each ser-
vice to obtain a range of views about the intervention, implementation
and design acceptability. Interviews were conducted between August
2017 and January 2018, either face-to-face during the final study visit
by research staff, or by telephone if AMS staff were not available on that
day. The interviews were audio-recorded and professionally transcribed
(intelligent verbatim).
2.5. Analysis
Descriptive analyses reporting counts and proportions were used for
recruitment and retention rates. Ninety-five percent confidence inter-
vals were calculated for the main outcomes (recruitment and retention
rates) using the Wilson method, as it is recommended for small sample
sizes. (Brown, Cai, & Dasgupta, 2001) For the critical success factors, a
cross-tabulation of the number and percentage of participants reporting
each of the two categories for how important they believed the factor
was (i.e. “not at all/a little/moderate” vs. “very/absolutely essential”)
compared to the two categories for how well participants thought the
program achieved the factor (i.e. “poorly/slightly/moderately” vs.
“very/extremely”) were reported for each of the nine critical factors.
Fig. 2. Flow chart for each site of recruitment and retention of pregnant women participants.
Legend: *Estimated from service data.
Pre-T= Pre-training (women recruited prior to services receiving training).
Post-T= Post-training (women recruited after services received training).
NA=non-applicable.
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Table 1
Secondary outcomes for ICAN QUIT in Pregnancy Pilot Study.
Outcome Result
a.) Survey completion rates
Pregnant women
Women's Smoking Characteristics Survey:
4-weeks: 68% (15/22)
12-weeks:77% (17/22)
GEM survey (at least one follow-up): 77% (17/22)
Critical Success Factors Survey: 45% (10/22) at end of study
Women's Checklist: 45 checklists were completed in total by 19 participants (average 2
per participant, range 1–6)
Note: one service did not collect the GEM or Critical Success Factors surveys due to
their length.
Health Providers⁎ HP Pre-training survey: n= 45/50=90%
HP Post-training survey (at least one survey completed): n=20/50=40%
b.) Agreement to audio-recording
Pregnant women






S6 n=0 (NA none recruited)




S5 n= (not known)
S6 n=NA
c.) Acceptance and Adherence to NRT 55% of women (12/22) accepted NRT
58% of these women (7/12) used the NRT, none took as directed:
2 took NRT ≥50% of the time; 5 < 50% of the time
d.) Efficacy of ICAN QUIT in Pregnancy for smoking cessation Quit attempts: 41% (9/22) made a quit attempt by 12weeks
Quit rate at 12 weeks: 13.6% (3/22 – intention-to-treat analysis) 7-day point-
prevalence and biochemically validated by exhaled CO readings ≤6 ppm
Continuous abstinence was achieved by 9.1% (2/22) at 12 weeks (all reported ‘not a
puff’ since quit date as per Russell Standard Clinical)
An additional woman achieved CO validated ≤6 ppm 7-day point-prevalence and
continuous abstinence at 4 weeks, but relapsed before 12weeks
e.) Intervention adherence
HP Training







Provision of NRT 55% (12/22) of women participants provided with NRT
f.) Use of research study forms by services HP training forms: used by 1 service (out of 6)
Eligibility forms for women: used by 1 service (out of 6)
CO-reading forms: 4 services (out of 5)
NRT vouchers: 2 services (out of 4 that dispensed oral NRT)
g.) Feasibility of monthly data (numbers of pregnant women smoking who attended the
service during study period, and NRT prescriptions⁎⁎ to any pregnant woman
attending the services, number of visits pregnant women made to the services)
S1 – provided data from May 2017, then monthly from November 2016 to April 2017,
then monthly as required until Sept 17. During the study period no NRT prescribed
S2 – as above for S1 (same IT person). During the study period no NRT prescribed
S3 – provided data in February 2017 that included data from November 2016 to
February 2017, then in October 2017 sent the rest of the data. Data included number of
visits for women at the service and smoking status. Could not provide NRT prescription
data.
S4 – started providing data in March 2017 (included November 2016 to March 2017),
after that monthly until September 2017. Five women in total prescribed NRT patch (1
before training, and 4 after), and 13 were offered a referral to the Quitline (4 prior to
training, and 8 after).
S5 - in September 2017 provided data from November 2016 to July 2017, then in
October 2017 sent data from July to September 2017. Only provided smoking status
monthly, and overall for all the study period (unsure if before training or after). One
woman received an NRT prescription.
S6 – did not provide any data.
h.) Fidelity of training timing by services Three out of 6 services were trained in the month scheduled. One service was one
month late due to the holiday period; two were two months late with training.
Legend: HP=Health Providers; S# is de-identified service number; NRT=Nicotine Replacement Therapy.
Percentages reported only where denominator> 10.
⁎ Some HPs completed post-training form near end of study, thus protocol was changed to require only one follow-up survey.
⁎⁎ NRT prescriptions did not include the oral NRT vouchers given by the services, but Pharmaceutical Benefit Scheme prescriptions for NRT patches written by any
HP in the AMS to a pregnant women irrespective if she was in the trial or not.
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This provided an indication of whether those factors participants
thought were important were also perceived to have been done well by
the program.
Qualitative data was analysed using a framework analysis, (Gale,
Heath, Cameron, Rashid, & Redwood, 2013) thus the data was coded
under categories of TDF, (Cane, O'Connor, & Michie, 2012) and BCW
(including the COM-B model i.e. Capability, Opportunity, Motivation -
Behaviour), (Michie, Atkins, & West, 2014) in addition to a general
inductive analysis to capture other emergent themes. (Thomas, 2006)
Capability, according to the BCW, comprises physical and psychological
components (such as physical and cognitive skills, knowledge and be-
haviour regulation); opportunity includes physical and social aspects;
and motivation includes reflective (through cognitive processes and
intentions), and automatic (via habits, emotions or reinforcement).
Twenty per cent of the transcripts were independently coded line by
line by two researchers (MB – a female Indigenous researcher) and GRG
- a female non-Indigenous researcher. The two researchers came to a
consensus for a coding book, then MB continued to code the remaining
transcripts. Analytic progress was periodically overseen by GSG. GSG
completed the framework analysis with the BCW and TDF. For addi-
tional analysis information refer to the published protocol (Bar-Zeev,
Bonevski, Bovill, et al., 2017).
2.6. Ethics
The study was approved by the following Human Research Ethics
Committees (HREC): University of Newcastle HREC (#H-2015-0438),
Aboriginal Health & Medical Research Council HREC (#1140/15),
South Australia Aboriginal HREC #04-16-652, Far North Queensland
HREC (#16/QCH/34 – 1040).
2.7. Trial registration
This study was registered with the Australian and New Zealand
Clinical Trials Registry (ACTRN12616001603404).
3. Results
Pregnant participants' flow through the study for each of the six
AMSs is presented in Fig. 2. Reasons reported by the RFs for women
declining (exact numbers not recorded by services): did not like RF, not
interested in the study, partner did not know she smoked, and wanted
to try to quit alone. Two reasons given were not actually exclusion
criteria: one woman stated she did not want to quit smoking, and an-
other woman was reported to not be Indigenous, (a woman was eligible
providing she was pregnant with an Indigenous baby, and irrespective
of her intentions to quit smoking).
3.1. Feasibility results
For the primary outcome of recruitment rate, sufficient data on the
number of eligible women was only provided by four of six services.
Services were given 6months to recruit women and three months to
follow them up, however a couple of services were allowed more time,
in case they could increase their numbers. Recruitment rates could only
be calculated in services one, two, three and four; these varied from
14% to 80%, with 47% (95% CI: 32%, 63%) overall (17/36). Service
five recruited five women, and service six none. Documentation was
problematic for service five due to a change in RF, and service six si-
milarly did not provide documentation on eligibility, commenting that
few eligible women attended in the time period of the study.
Recruitment for the HPs was calculated from services providing data
that 93 HPs worked at the services. Fifty of these consented to the
study, resulting in a recruitment rate of 54% (95% CI: 44%, 64%).
Recruitment rate ranged from 33% to 72% at the sites. HP types re-
cruited were: 17 GPs, 17 nurses/midwives, 10 AHWs, 6 others (e.g.
family strengthening worker). Several HPs had multiple roles.
Retention rates for pregnant women were provided from five ser-
vices (one not applicable), and varied from 60% to 100%, with an
overall retention rate of 77% (95% CI: 57%, 90%) (17/22). HP reten-
tion rate was 40% (95% CI: 28%, 54%) overall (20/50). Secondary
outcomes are reported in Table 1.
3.2. Acceptability results
3.2.1. Critical success factors
A total of 10 out of 22 pregnant participants completed the critical
factors survey (45%). There were no duplicates or missing data points.
For each of the nine items, Table 2 presents the percentage and fre-
quency of participants who reported the level of importance as “not at
all/a little/moderate” vs. “very/absolutely essential”, compared to
whether they indicated that the program achieved the factor “poorly/
slightly/moderately” vs. “very/extremely”. As shown in
Table 2 > 50% of participants indicated that each of the nine factors
were “very/absolutely essential” to the program's success. Simi-
larly,> 50% of participants reported that the program achieved each
factor “very/extremely” well. Furthermore, agreement between parti-
cipants perceived level of importance and their perceptions of how well
they believed the program addressed each factor was high (≥ 90% in
all cases), with only two items “Adopting full commitment to working
from strengths, not seeking to correct deficits” and “Facilitating con-
nection to culture, showing how to be strong Aboriginal or Torres Strait
Islander person through individual, group and community engage-
ment”, illustrating a discordance in responses by one participant.
3.2.2. Qualitative data from interviews for acceptability
Eighteen interviews were conducted from six AMSs comprising: six
RFs, four managers, four GPs, two HW, and two midwives. Interviews
lasted from 7 to 72min (mean 29min). TDF findings are annotated with
‘TDF’ followed by the relevant domain. The analysis presented under
the domains of the COM-B model considers both the feasibility and
acceptability of the research study conducted at the AMSs, its inter-
vention, and implementation. Analyses are presented below, and re-
presentative quotes are in Table 3.
3.2.2.1. Capability
3.2.2.1.1. Physical capability. Building capacity within the service
was vital from a managerial level. Managers in particular highlighted
the importance of physical capability for service and capacity on an
organisational level.
3.2.2.1.2. Psychological capability3.2.2.1.2.1. Education and training
There was evidence of psychological capability increasing through
the education and training, and that the content was acceptable to a
wide range of staff. Conducting the training at the AMS was seen to
increase service capability. It was also beneficial to have managers at-
tend training, so they could understand required capacity from a service
level. Staff, in general, highly praised what they had learnt through the
webinar training and commented favourably on quality and compre-
hensiveness of the content. Even though the webinar was broken up
with interactive sessions and videos, more of this type of content, in-
cluding case studies were requested, supplemented with graphics and
animation. There was evidence HPs were then able to offer an increased
level of support to pregnant women who smoke and make changes to
routine practice (TDF belief about capabilities). HPs and RFs expressed
enhanced confidence in knowing how to use NRT and promote it to
women. Whereas before they might not have been confident to de-
monstrate the products or challenge a woman if she expressed re-
luctance, HPs now felt enabled to provide NRT as an option and discuss
its benefits and relative safety, compared to continued smoking (TDF
memory, attention, decision-making processes).
Being involved in the research project and the intervention, enabled
many HPs to take the new practices into routine care, thus giving
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Table 3
Interview data categorised into the COM-B model with participant interview excerpts.
Capability
Physical capability
Capacity-building “..the aim is to help pregnant women quit, but it also - it's built in the capacity of the service to actually be able to do
that…” Manager
“…Research doesn't have to be just taking from the organisation and us giving all of this time and all of this data. It can be
something where the organisation can benefit as well.” Manager
Psychological capability
Knowledge and cognitive skills from the training “My senior social worker here and the social emotional wellbeing worker and, you know, the Aboriginal [HW] - the
midwife and the GP, they all understood it [webinar] really good and they thought it was fantastic information.” RF
“I participated in the training - you know, partly for my own benefit and to see what happens…but what I was interested
in was increasing the capacity of the organisation really. So I looked at it as a capacity building exercise to have this
training, get staff on board because they're all aware of smoking and how important it is to help women stop” Manager
“And it's training that we can use again and again and again. It's not just a, yeah, once-off thing.” RF
Decision processes and behavioural regulation “So instead of talking to them and then saying ‘Well, this is the sort of follow-up we've got’, I found it a lot easier
to have that conversation and to be able to offer them their support.” GP
“I was [offering NRT before], but most women say to me no, they'd rather do it without it, and I never presented
them with an alternative argument as far as statistics go and the likelihood of success in quitting. So I'm more
likely to challenge their understanding of NRT now.” Midwife
“… we've got her smoking status flagged now, which we didn't have before the project. So that's a change that will
be ongoing.” GP
“… we've really increased the number of brief interventions that are recorded…” Manager
“It made me more inclined to make smoking in pregnancy more of a priority when there's so many things to talk
about at the start.” GP
Research capability and impact of the RF role “She's [RF] just an exceptional person in being able to manage all this.” Manager
“It was worth all that time and effort that took me away from my role.” RF
“It [RF role] hasn't really a major impact on what I do. It just gave me extra information which we pass on or that we can
see if there's any changes.” RF
“I'd probably say be aware that it's going to take a bit of time and impact you a little bit…I think I probably had the busiest
time I've had in five years over that whole period, so I think you have to be prepared for that really, for a bit of extra
work…be prepared to put in a little bit of extra effort.” RF
Opportunity
Physical opportunity
NRT supplies “There weren't a lot that took that offer up, but the ones that did, said, “Yeah, it might be a good idea to give that a shot.”
RF
“We even had people come – coming in and asking for them..So they were in the drawers here, we were able to say “What,
do you want some – what would you rather? …the chewing gum? …the lozenges? …the patch?” Health Worker
“I think if there were clinicians who were still on the fence it probably would have had a negative impact not having had
the webinar training before the program started.” GP
Environmental context and resources “…it enhanced our already existing service where we're trying to help women to quit. I think having the flipchart and
having posters in the waiting room, having handouts in the waiting area before they see the doctor…. We did have some
information, but probably it wasn't as good as what's been available through the research.” Midwife
“I thought the flipchart was great. I thought it was excellent… a lot of women think that in pregnancy they can't have
nicotine replacement therapy, so being able to say to them ‘Yes, you can have this’.” Midwife
“… it puts a positive face of an Aboriginal woman, this is her place, this is her with her family and this is her using NRT….
GP
“[Resources were]..really good, really informative and gave you lots of sort of answers to when you were asking
questions, or when other people asked questions.” Health Worker
Social opportunity
Patient Journey “My role was, was that I would start discussions with women which I generally do when they're pregnant about …
cessation of smoking, and then our midwife would be working hand in hand. So she would then see the patient and recruit
the patient, sign the consent. Then we [doctors] would initiate the nicotine replacement therapy.” GP
“I was not notified who was in the study and who wasn't, meaning even if on the day I could just get a little note in the
chart before I open it to say ‘This patient's enrolled’ then I could potentially look at it with a different hat on than just the
usual way…I would have liked to have been able to say 'Look, you signed up on this day and how is it going now?” GP
I think giving me an opportunity to connect with the pregnant women through that role was really good, but also learning
a lot from that in my - you know, to use with my current role as well. RF
(continued on next page)
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evidence of sustainability of implementing smoking cessation care more
effectively. This ranged from being more systematic about recording
smoking status and brief interventions, to counselling women and of-
fering support (TDF memory, attention, and decision processes, and
behavioural regulation). Attitudes to and mode of recommending NRT
changed giving HPs a stronger knowledge base, and confidence (TDF
knowledge and belief about capability).
“I have a much better understanding of the benefits of NRT and I'm much
more likely to promote the use of it…” Midwife
3.2.2.1.2.2. Research capability
Research was not the core business of the AMSs that participated.
For several it was a new venture; some AMS reported having partici-
pated in prior research, and a few had not found it beneficial:
“I think that all of those things your project is trying to break down…
because for a long time research has just been taking from organisations like
this.” Manager.
Staff from the services noted their experience with ICAN QUIT in
Pregnancy was rewarding, and the research team provided an ex-
emplary level of communication. It was vital to the smooth-running of
the project that the person in the RF role had the capacity to take it on,
was a good fit and had managerial support. Most RFs expressed they
benefitted from being in the role, and built their own knowledge, ex-
perience and capability.
3.2.2.2. Opportunity
3.2.2.2.1. Physical opportunity. Webinar was chosen as the training
delivery mode to accommodate challenges of rurality of many of the
AMS. Managers appreciated the convenience of this mode of training,
saving on costs of staff traveling to a main centre and days lost through
absences. However, challenges remained in organising all staff to attend
the webinars on one occasion. In some services doctors missed the
training because they were not released from clinic time or could not be
financially reimbursed for clinic time lost. In others, doctors did not feel
sufficiently motivated or incentivised to attend.
Most services opted to have three one-hour sessions in a single
sitting, because of challenges of getting staff together. This resulted in
many staff commenting that the webinar was too long, or too much to
take in one occasion. All services received individual recordings of their
webinar sessions for staff to follow up and view later if they missed the
training.3.2.2.2.1.1. NRT supplies
Oral NRT at the time was not subsidised in Australia. However,
these forms are preferred as a first-line treatment for smoking cessation
in pregnancy. (Zwar, Mendelsohn, & Richmond, 2014) Having oral NRT
sample packs and supplies on site provided a major opportunity to
improve access to NRT (TDF environmental context and resources) and
was highly regarded by most. It facilitated women accepting NRT and
being willing to give it a trial.
Alternately, HPs not attending the training (or not completing it)
had an impact on women having access to NRT. Several interviewees at
one service reported they became aware that a few women, who had
been previously willing to take NRT, were then told by a doctor it was
safer to continue to smoke at a low level than take NRT, and subse-
quently declined to accept the NRT supplies.3.2.2.2.1.2. Resources
Training resources were useful tools. The flipchart to guide the pa-
tient consultation was used in various ways by staff members, sometimes
by showing a favourite page or two to reinforce discussions about NRT,
or displaying a particular photo showing a woman using NRT which
attracted interest from several pregnant women (TDF social influences).
Posters were provided showing different types of NRT or comparing
chemicals in a cigarette to those in NRT and were often displayed
around the AMS or within the HP offices. They served to educate
women, restructure the environment and act as prompts (TDF en-
vironmental context and resources). Similar to the flipchart, posters
modelled to women that NRT was safe by showing Indigenous women
in the photos actively using NRT, for example an oral spray (TDF social
influences). A mouse mat was intended to serve as a desktop prompt
about the main ABCD features of the smoking cessation care and how to
titrate NRT to patient's dependence indicators. However, it did not
appear to be used as a prompt and found to be less useful. Overall the
combined presence of resources had a powerful impact to restructure
the AMS environment, towards the better provision of SCC in the
Table 3 (continued)
Capability
Social influences and social modelling It's only been from talking with [RF] that I've actually had the confidence to talk to people about using an oral spray ….if
you can explain to someone this is how a product works and I have confidence in this product and you could use this
product this way, I think they're more likely to take it up….” GP
“I think it was good to have you guys come back and give us the broader picture of what's happening in the other services,
and I think it's quite valuable. … as you say, in your pilot you've got over a 10% quit rate. That's really meaningful, but at
the time, when you say I've got eight women and seven of them didn't quit. Why are we doing this? It's so hard. I think
giving that bigger picture that says the quit smoking rate in pregnancy is 3% you said today…We've only run this project
for six months and one out of eight of our women quit, so that's more than the average. We're doing really well.” GP
Motivation
Reflective motivation
Motivation for HPs to help pregnant women quit, and
recommending NRT
“I think - before having that conversation with [trainer], I probably was thinking more along the lines of ‘how do you feel
about quitting’, whereas, yes, I have shifted to the, ‘How do you feel about trying NRT now?’ “GP
Goals and intentions “…the project has made me more aware of being more rigorous, more systematic in terms of checking people's smoking
status and intervening more often and we've now got our computer system assisted so that we're working on every single
visit, checking where they're up to with their smoking. I think that's something that we've changed, because previously we
would check in the beginning and then sporadically we would ask how things were going…” GP
Automatic motivation
Motivation and reinforcement for HPs and pregnant women “… the one pregnant mum that quit, seeing her realise that that number [on Smokerlyzer] was not a good thing and
actually making that real effort to get that number down and seeing how proud she was at the end of that, I think was
really good for me to see, like - and seeing all the babies born, of course, that's, you know - and all healthy. All, you know,
beautiful, healthy little babies, which that was, yeah, fantastic, enjoyable.” RF
“The incentive of the gift card was fantastic, because quite often these women are, you know, living payday to payday
and, you know, it comes in handy when you're expecting a new baby or when you've had a new baby. RF
Another thing about it [booklet] that was good, it didn't throw up all the negatives. …’This is the problems that can
happen.’ But it was more of a positive thing, you know, ‘This is what we've got to offer’, ‘This is what we can do for you’,
‘This is the support you can have’, those sorts of things.” Midwife
Legend – GP=general practitioner; NRT=Nicotine Replacement Therapy; RF= research facilitator.
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context of tackling Indigenous smoking during pregnancy.
3.2.2.2.2. Social opportunity. When staff saw others providing
smoking cessation care, it enabled teamwork and a common purpose.
Recruitment of the women was not seen as problematic in many of the
services, who reported success from the flexible approach offered by the
research team. Face-to-face recruitment of women was preferred.
Several services planned ahead by looking at the antenatal clinic
appointment list and screening that way for eligibility. Women who
did sign up were said to be “eager about it” RF. Having a trusted
relationship with the RF or other staff was a benefit for recruitment, but
conversely personal barriers with staff and shyness were reported as
barriers. In many cases, study recruitment provided an opportunity for
a team approach, and helped navigate the patients' journey through the
service, and their journey towards smoking cessation.
Some staff expressed their needs for social opportunity could have
been further met within the service by having team meetings about the
project, and briefings to understand how the women participants were
going. Having a system that helped HPs know which women were in the
project was valued, so they could make sure they would inquire about
their progress. This was achieved in one AMS by organising before the
antenatal patients came in who they would need to see on a particular
visit and aiming for all required HPs and the RF to be seen before the
patient left the service. In services where this did not occur there was a
potential project disconnect. One service found communication about
who was participating in the study a challenge, and the GP providing
this information suggested ways this could be remedied.
Social modelling was achieved through whole of service training,
and instruction on providing SCC by credible sources (Tobacco
Treatment Specialists and Indigenous presenters). Webinar videos
showed positive attitudes of other HPs providing SCC to Indigenous
women in pregnancy and were intended to build optimism. There was
also evidence of staff communicating with each other to improve their
own knowledge and confidence for using different aspects of the in-
tervention and promoting them to pregnant women.
The audit and feedback approach was hampered by delays getting
service-level data from the AMSs in the time-frame of a short pilot
study, thus was not feasible. However, interviewees did express
wanting more social opportunities to reflect on their own performance
and compare themselves to others. More social comparisons may have
improved project understanding (TDF memory, attention and decision
processes) and staff motivation (TDF beliefs about capabilities, and
intentions). At the wrap-up site visits, the research team presented
Table 4
Suggested improvements for the intervention and the research.
Aspect of the study Suggested improvement Representative quote
Research related suggestions
Research facilitator role Train two staff as back-up for RF role or split the role, so one
recruits another follows up.
“So they look at the midwife more as being that therapeutic role, and being that
support, doing the smoking cessation…You take away that coalface data stuff and
give it to more another role that it then allows the person to separate it a bit.”
Manager
A good fit for role is important, and RF having time and
motivation to do it.
“…the staff needs to have that time available to be able to do it. Do it the right way.
Not have someone that's got to wear a number of hats and then it falls over.”
Manager
Overall management at AMS
sites
Managerial support and oversight “To have one person overseeing the project and just making sure that things are
running smoothly in terms of different points throughout the study.” RF
“…it's probably easier when there's a lot of managerial support behind a research
project.” Manager
Research facilitator training Dedicated workshop for RF training “You could improve it by…before you're rolling it out, having that workshop before,
so whoever's going to be the facilitator – and with the facilitators, the doctors, the
health workers and the midwife, maybe have a workshop beforehand, before actually
running that, so everyone's on the same page…” RF
Recruiting women Alternate ways to recruit “I would probably actually host a day… To launch the project…I would have done it
a bit differently. Because it's actually putting it out there and asking them to talk to
the health worker themselves and let them know…” RF
Following-up women Recommended a method used in another pregnancy clinic to
ensure women are seen by relevant HPs and the RF
“…there's a slip that has a list of all possible providers that are part of that clinic and
it's ticked which of the providers they need to see and then when those providers see
them, they sign the slip and then the woman don't leave the building until all the
people that they're supposed to see have signed off that they've seen them.” GP
Step-wedge design of study Start the training at the beginning of the project: avoid step-
wedge pre-post design
“I think that was confusing for services in general, that they were - some just didn't
know why they weren't getting it [training] straightaway because normally when a
project starts you get it straightaway.” RF
Length of study Study length should be at least 12months: services were just
getting into their stride when the study finished
“…realistically you need a good 12months from way to go, from start to finish.
Having a nine month timeframe, just as long as a baby, is not enough, because it's got
to build momentum.” RF
Surveys Reduce length and repetitive nature of surveys. “Get rid of that checklist. Delete the checklist. I think everything else was really
good.” RF
“I think they found them quite wordy and asking the same thing over and over
again…” RF
“… the GEM was so long and so big…‘Now, this one is that long one. Do you
remember? It's the heavy questions and that, so just take your time.’ …I really had to
just remind them to expect that… anything to do with social and emotional stuff is
going to be challenging, especially… if you had a bad week.” RF
Intervention related suggestions
Improving social modelling Case-studies for training e.g., videos showing how to counsel
and prescribe NRT. Also to convey others' experiences of the
intervention.
“‘Here's a short video of where we've run this program before.’ Let's talk to the
midwives and the doctors and chat to – if patients wanted to talk about what they've
been through and ‘This is what they thought of what we were doing.’” Midwife
Newsletters with content to engender social comparisons. Link-
ups with other AMS in the project for comparison and support.
“Sometimes I've found when I've been part of research projects before, that getting a
newsletter and saying ‘These are how many centres’, having a picture ‘X's doing
really well’ or ‘So and so at Y'… it would probably be good to have ongoing emails
with just a newsletter or project update.” Midwife
Legend: GEM – Growth and Empowerment Measure; NRT=Nicotine Replacement Therapy.
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comparative data to the services and this was appreciated by AMS staff
to understand their place in the research, assess what they had
achieved, and feel optimistic about the future (TDF social influences,
optimism and behavioural regulation).
3.2.2.3. Motivation
3.2.2.3.1. Reflective motivation. The first hour of the webinar
training was explicitly aimed at motivating HPs and improving
optimism for providing SCC to Indigenous pregnant women, and to
improve HPs' belief in their capability to do so. There was evidence that
smoking was re-framed as an addiction (TDF beliefs about
consequences) by HPs, which was also one of the aims of the
training. Staff reported that what motivated them during the project
was seeing results (TDF beliefs about consequences) in two main ways:
1) Having the project at their AMS increased their engagement with
pregnant Indigenous women who smoke, which in the past had been
challenging:
“…when I first started this, one of our priority groups that was high-
lighted was pregnant mothers who smoke. Getting in to - and, I guess,
engaging with those women, is difficult…. A lot of the time they feel like
they're being targeted, judged. You know, they feel like they're ashamed
of their history of smoking or that they're still smoking in pregnancy…
unfortunately, a lot of the pregnant women that we had here were past
the 28-week line. But those pregnant were that were involved in the study
said, ‘You know, if you want to quit smoking, you can go and see the TIS
team, even though you're not involved in the study.’ So, for us, that was a
really big benefit, because it gave us the opportunity to have connection
with those pregnant women that we otherwise probably wouldn't have
had.” RF
2) Seeing women's success in quitting smoking. “I think it was great that
a couple of women gave up smoking. That was fabulous.” RF. The latter
was also facilitated by the use of the CO meter to provide the women
with self-monitoring, biofeedback and positive reinforcement.
3.2.2.3.2. Automatic motivation. Vouchers of AUD $20 value each
were given to women at each evaluation point, but not contingent on
quitting. Nonetheless, staff reported that the vouchers were considered
an incentive and a re-enforcement for women to participate in the
research.
Staff liked that resources did not overly promote negative aspects of
smoking; messages were positively pitched, aiming to increase self-ef-
ficacy in pregnant women to quit smoking. ICAN QUIT in Pregnancy as
a whole was seen to be a worthwhile experience by most staff inter-
viewed. This quote emphasised the positive and meaningful nature of
the benefits.
“I think learning about these things and getting some data and seeing
where it goes is really, really positive, and if we can get women reducing
or ceasing smoking in pregnancy, what a fantastic thing for the future for
their children.” Manager
3.2.2.4. Suggested improvements for the research. One emergent theme
centred on how the research could be improved. These suggestions are
outlined in Table 4.
4. Discussion
Feasibility and acceptability data obtained from six AMSs in three
states were analysed from the ICAN QUIT in Pregnancy study. The
numbers of women recruited at n=22 was less than the 50–80 parti-
cipants expected, partly due to a lack of eligible women at the time in
some services, the short time-frame of the project, and services taking
time to get familiar with the study. (Bar-Zeev, Bonevski, Bovill, et al.,
2017) However, the recruitment rate of women was close to the ex-
pected 50% at 47% (determined from four of six services that tracked
this data accurately). The planned patient recruitment for the larger
trial will be 15 women per service over a period of two years, with an
intension that 30 sites will be recruited, and a total sample of N=450
women. We believe that allowing this extended recruitment time would
account for seasonal variations in pregnancy rates, and thus be feasible.
The numbers of HPs recruited (n=50) was in the expected range of
30–60. (Bar-Zeev, Bonevski, Bovill, et al., 2017) HP recruitment was
satisfactory at 54% (50/93), and 39 HPs completed the training: 78%
trained was close to the 80% predicted. (Bar-Zeev, Bonevski, Bovill,
et al., 2017) Retention rates were 77% for women, and 40% for HPs.
Survey completion rates varied by site from 45% to 77% for the women,
and 40% to 90% for the HPs. Agreements to audio-record consultations
varied among sites from 0% to 100% for women, and 0% to 83% for
HPs. Some data collection tools for process measures were not used as
intended. HPs' training forms and eligibility forms for women were each
used by only one service; CO-reading forms were used by four services,
and NRT forms were used by two services. These forms will need to
either be replaced by more effective methods, or more emphasis given
on data collection in the RF training.
The critical success factor survey results demonstrated, in the 10
women who completed them, that there was a concordance of over 90%
between women who felt the factors were important, and the ability of
the project to positively achieve that success factor. Qualitative inter-
view data provided BCW and TDF commentary about how the inter-
vention, its implementation, and the research process measured up
according to capability, opportunity and motivation. Strong points for
the implementation were the resources, including training materials,
patient resources, equipment (CO meters) and oral NRT. These in-
creased capability and opportunity, helped restructure the environ-
ment, and provided social comparison and modelling. Staff were mo-
tivated by greater engagement with pregnant women. They were also
inspired by the women's CO readings decreasing (indicating less ex-
posure to tobacco smoke), and some women stopping smoking com-
pletely (thus CO readings reducing to the non-smoking range). Having
research at the AMSs on the whole improved organisational capacity
and RF capability. Staff reported making changes to their routine
practice that were potentially sustainable. Most services felt the extra
workload was worthwhile to improve the health of mothers and infants
in a very high-priority area. Valuable feedback was given for areas for
improvement particularly for webinar training and reducing the vo-
lume and type of research data collected. For the larger trial, survey
length will be reduced and surveys will be combined into a single in-
strument, for example the women's checklist incorporated in to the
main surveys.
4.1. Comparison with other studies
Measuring recruitment rates is an important aspect of feasibility
studies. Recruitment rates varied in previous feasibility studies of
smoking cessation among pregnant Indigenous women, from 12% to
58%. (Glover et al., 2015; Passey & Stirling, 2018; Patten et al., 2010)
Our recruitment rate of 47% is quite reasonable in this context. Re-
tention rates in feasibility studies varied from 37% to 86%, compared to
our relatively high retention rate for the women of 77%, although these
figures are potentially imprecise due to low sample sizes. These feasi-
bility studies varied in their measures of feasibility and acceptability,
with our study being more detailed than most others to date.
Only one Australian study, conducted in 22 pregnant Indigenous
Australian women in three rural Aboriginal Maternal and Infant Health
Services in New South Wales in 2010–2012, reported additional mea-
sures. (Passey & Stirling, 2018) This study of a complex intervention
had a recruitment rate of 58%, and a high retention rate of 86%.
(Passey & Stirling, 2018) Feasibility was determined by implementation
of the key components of the intervention, and acceptability by enrol-
ment and completion, and interviews. Visual aids, resources and free
NRT were well-received though implementation challenges were
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described. One site withdrew due to lack of capacity and staff shortages,
and engagement of some women was difficult. Recommendations for
improvement centred around service capacity and sustainability.
Factors reported as being important in a 2012–2013 New Zealand
with Maori pregnant women (n=24; recruitment rate 32%; retention
rate 37.5%), (Glover et al., 2015) included low recruitment when a HP
was involved. The tenor of trial promotion may have influenced a
pregnant woman's ability to enrol and stay engaged. (Kira, Glover,
Walker, & Bauld, 2016). A 2007–2008 feasibility RCT for a complex
intervention conducted among US Alaska Native pregnant women
(n=35) had a low recruitment rate of 12%; but high average retention
rate of 84%. (Patten et al., 2010) Authors concluded that the low re-
cruitment, hampered by women feeling stigmatised by the enrolment
process and not having time to participate, suggested the program was
not feasible or acceptable. (Patten et al., 2010)
The step-wedge design in our trial was confusing for services that
were used to getting a new intervention straight away rather than
having a period of usual care, followed by the intervention. Step-wedge
designs have been reported as complex to execute in real-world settings
especially when individual consent is required, and delays with re-
cruitment can frequently impact study outcomes. (Heim et al., 2017)
Routine data have previously been reported as less accessible than ex-
pected and retrieval of data highly delayed. (Heim et al., 2017) These
issues combine to cause a lower than expected sample size. Only 12
cluster randomised step-wedge designed studies have been conducted
previously in Australasia, and their practical challenges are rarely re-
ported. (Grayling, Wason, & Mander, 2017)
4.2. Strengths and limitations
One strength of our study is its theoretical design, and planned
approach to measuring feasibility.
and acceptability with a protocol paper published a priori. (Bar-
Zeev, Bonevski, Bovill, et al., 2017) A RF who was an existing staff
member of the AMSs likely helped engagement and retention rates. In
recognition of the diversity of Australian Indigenous populations and
contexts, the study was deliberately conducted in three Australian
states to aid generalisability and transferability of findings, in pre-
paration for a full trial. However, regional differences will occur in all
states. New South Wales was better covered with four services enrolled;
having only one service in South Australia and Queensland might limit
generalisability for those states. The pilot feasibility study provided a
wealth of data to inform the decisions needed for a full trial in five
states (SISTAQUIT® – Supporting Indigenous Smokers To Assist Quit-
ting trial registration ACTRN12618000972224). (Gould, 2017) Due to
the feedback from this pilot, the SISTAQUIT® trial is planned as a
cluster RCT using a standard design. Recruitment and retention rates
are guiding decisions about the sample size required for the larger
study.
The study length of nine months is typical for a pilot study, however
in the context of pregnancy seemed short for the services, who gave
feedback that they would have preferred a longer follow-up. This was
an unforeseen response, as researchers were very conscious of not
burdening the sites for longer than necessary. The women were only
followed up for 12weeks, as we considered most quitting activity
would occur during that timeframe.
5. Conclusion
ICAN QUIT in Pregnancy as a complex implementation intervention
was well-received, feasible and acceptable in AMSs across all three
states, with modifications recommended for the length of webinar
training. For the research itself, changes were recommended for data
collection and the step-wedge design. Smoking in pregnancy is a key
challenge for Indigenous health. Training HPs and providing resources
has a high potential to improve outcomes for Australian Indigenous
women and infants. This pilot study enabled implementation challenges
to be addressed before initiation of a major study. This study appro-
priately considered cultural and other contexts of the services, so spe-
cific needs of the Indigenous community could be addressed. By as-
sessing and reporting feasibility, acceptability and the measurement of
process data, we can better account for the implementation of the in-
tervention and the research.
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